• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿托伐他汀可减缓小鼠内耳功能随年龄增长的衰退。

Atorvastatin slows down the deterioration of inner ear function with age in mice.

作者信息

Syka Josef, Ouda Ladislav, Nachtigal Petr, Solichová Dagmar, Semecký Vladimír

机构信息

Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Vídenská 1083, 14220 Prague, Czech Republic.

出版信息

Neurosci Lett. 2007 Jan 10;411(2):112-6. doi: 10.1016/j.neulet.2006.10.032. Epub 2006 Nov 7.

DOI:10.1016/j.neulet.2006.10.032
PMID:17084973
Abstract

Statins have revolutionized the treatment of hypercholesterolemia due to their ability to inhibit cholesterol biosynthesis. Their immunomodulatory and anti-inflammatory effects and positive effects on the treatment of atherosclerosis and its complications are well known. Here, we describe the effects of statins on the treatment of presbycusis in C57BL/6J mice. In this strain with accelerated aging, we demonstrate that animals treated with atorvastatin (10mg/kg per day in chow diet) for 2 months showed larger amplitudes of distortion product otoacoustic emissions (DPOAE) than did the non-treated control group. This finding indicates a better survival of outer hair cell function in the inner ear of C57BL/6J mice. The observed decreased expression of intercellular and vascular adhesion molecules in the aortic wall of atorvastatin-treated animals suggests that reducing endothelial inflammatory effects may contribute to the positive effect of atorvastatin on the amplitudes of DPOAE by influencing the blood supply to the inner ear. No such beneficial effect of statins was found in apoE(-/-) mice treated with atorvastatin under the same conditions. Our results suggest that statins could also slow down the age-related deterioration of hearing in man.

摘要

他汀类药物因其抑制胆固醇生物合成的能力,彻底改变了高胆固醇血症的治疗方式。它们的免疫调节和抗炎作用以及对动脉粥样硬化及其并发症治疗的积极作用是众所周知的。在此,我们描述他汀类药物对C57BL/6J小鼠老年性聋治疗的影响。在这种加速衰老的品系中,我们证明,用阿托伐他汀(在饲料中每天10mg/kg)治疗2个月的动物,其畸变产物耳声发射(DPOAE)的幅度比未治疗的对照组更大。这一发现表明C57BL/6J小鼠内耳外毛细胞功能的存活情况更好。在阿托伐他汀治疗的动物主动脉壁中观察到细胞间和血管黏附分子表达降低,这表明减少内皮炎症效应可能通过影响内耳的血液供应,对阿托伐他汀对DPOAE幅度的积极作用有所贡献。在相同条件下用阿托伐他汀治疗的载脂蛋白E基因敲除(apoE(-/-))小鼠中未发现他汀类药物的这种有益作用。我们的结果表明,他汀类药物也可能减缓人类与年龄相关的听力衰退。

相似文献

1
Atorvastatin slows down the deterioration of inner ear function with age in mice.阿托伐他汀可减缓小鼠内耳功能随年龄增长的衰退。
Neurosci Lett. 2007 Jan 10;411(2):112-6. doi: 10.1016/j.neulet.2006.10.032. Epub 2006 Nov 7.
2
MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.MDOC和阿托伐他汀在载脂蛋白E基因敲除小鼠动脉粥样硬化模型的血管内皮中具有潜在的抗炎作用。
Life Sci. 2006 Mar 20;78(17):1983-9. doi: 10.1016/j.lfs.2005.08.041. Epub 2005 Nov 21.
3
Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.阿托伐他汀对载脂蛋白E/低密度脂蛋白受体双敲除小鼠具有降血脂和抗炎作用。
Life Sci. 2008 Mar 26;82(13-14):708-17. doi: 10.1016/j.lfs.2008.01.006. Epub 2008 Jan 26.
4
Atorvastatin has distinct effects on endothelial markers in different mouse models of atherosclerosis.阿托伐他汀在不同的动脉粥样硬化小鼠模型中对内皮标志物有不同的影响。
J Pharm Pharm Sci. 2006;9(2):222-30.
5
Auditory efferent feedback system deficits precede age-related hearing loss: contralateral suppression of otoacoustic emissions in mice.听觉传出反馈系统缺陷先于年龄相关性听力损失:小鼠耳声发射的对侧抑制。
J Comp Neurol. 2007 Aug 10;503(5):593-604. doi: 10.1002/cne.21402.
6
Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice.阿托伐他汀通过下调小鼠单核细胞趋化蛋白-1的合成抑制激光诱导的脉络膜新生血管形成。
Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1839-43. doi: 10.1167/iovs.06-1085.
7
Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.阿托伐他汀通过抑制 5-脂氧合酶通路和 CCL3 的表达来减轻载脂蛋白 E 基因敲除小鼠的动脉粥样硬化病变。
J Cardiovasc Pharmacol. 2013 Aug;62(2):205-11. doi: 10.1097/FJC.0b013e3182967fc0.
8
Effect of atorvastatin on progression of sensorineural hearing loss and tinnitus in the elderly: results of a prospective, randomized, double-blind clinical trial.阿托伐他汀对老年人感音神经性听力损失和耳鸣进展的影响:一项前瞻性、随机、双盲临床试验的结果
Otol Neurotol. 2007 Jun;28(4):455-8. doi: 10.1097/01.mao.0000271673.33683.7b.
9
Antiarrhythmic effect of atorvastatin on autoimmune myocarditis is mediated by improving myocardial repolarization.阿托伐他汀对自身免疫性心肌炎的抗心律失常作用是通过改善心肌复极来介导的。
Life Sci. 2007 Jan 23;80(7):601-8. doi: 10.1016/j.lfs.2006.11.045. Epub 2006 Dec 15.
10
Endothelin-mediated vasoconstriction in early atherosclerosis is markedly increased in ApoE-/- mouse but prevented by atorvastatin.在早期动脉粥样硬化中,内皮素介导的血管收缩在载脂蛋白E基因敲除(ApoE-/-)小鼠中显著增加,但阿托伐他汀可预防这种情况。
Exp Biol Med (Maywood). 2006 Jun;231(6):806-12.

引用本文的文献

1
Pathophysiological insights and therapeutic developments in age-related hearing loss: a narrative review.年龄相关性听力损失的病理生理学见解与治疗进展:一项叙述性综述
Front Aging Neurosci. 2025 Aug 20;17:1657603. doi: 10.3389/fnagi.2025.1657603. eCollection 2025.
2
Transcriptome sequencing reveals regulatory genes associated with neurogenic hearing loss.转录组测序揭示了与神经性听力损失相关的调控基因。
BMC Med Genomics. 2025 Jan 14;18(1):11. doi: 10.1186/s12920-024-02067-3.
3
Cisplatin-Induced Hearing Loss, Oxidative Stress, and Antioxidants as a Therapeutic Strategy-A State-of-the-Art Review.
顺铂诱导的听力损失、氧化应激与抗氧化剂作为一种治疗策略——最新综述
Antioxidants (Basel). 2024 Dec 21;13(12):1578. doi: 10.3390/antiox13121578.
4
Hearing loss during chemotherapy: prevalence, mechanisms, and protection.化疗期间的听力损失:患病率、机制及保护
Am J Cancer Res. 2024 Sep 25;14(9):4597-4632. doi: 10.62347/OKGQ4382. eCollection 2024.
5
Association between the atherogenic index of plasma and hearing loss based on a nationwide cross-sectional study.基于全国性横断面研究的血浆致动脉粥样硬化指数与听力损失的相关性。
Lipids Health Dis. 2024 Apr 29;23(1):125. doi: 10.1186/s12944-024-02119-8.
6
Age-related hearing loss: An updated and comprehensive review of the interventions.年龄相关性听力损失:干预措施的最新全面综述
Iran J Basic Med Sci. 2024;27(3):256-269. doi: 10.22038/IJBMS.2023.72863.15849.
7
Effect of statins on hearing outcome in patients with idiopathic sudden sensorineural hearing loss.他汀类药物对特发性突发性感音神经性听力损失患者听力转归的影响。
Laryngoscope Investig Otolaryngol. 2023 Oct 17;8(6):1631-1636. doi: 10.1002/lio2.1170. eCollection 2023 Dec.
8
Future Pharmacotherapy for Sensorineural Hearing Loss by Protection and Regeneration of Auditory Hair Cells.通过保护和再生听觉毛细胞实现感音神经性听力损失的未来药物治疗
Pharmaceutics. 2023 Feb 26;15(3):777. doi: 10.3390/pharmaceutics15030777.
9
Atorvastatin is associated with reduced cisplatin-induced hearing loss.阿托伐他汀可降低顺铂引起的听力损失。
J Clin Invest. 2021 Jan 4;131(1). doi: 10.1172/JCI142616.
10
Increased atherogenic index in the general hearing loss population.一般听力损失人群中动脉粥样硬化指数升高。
Open Med (Wars). 2020 May 23;15(1):349-357. doi: 10.1515/med-2020-0003. eCollection 2020.